These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8989828)

  • 1. Tissue transglutaminase and factor XIII in cartilage and bone remodeling.
    Aeschlimann D; Mosher D; Paulsson M
    Semin Thromb Hemost; 1996; 22(5):437-43. PubMed ID: 8989828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow-dependent remodeling of small arteries in mice deficient for tissue-type transglutaminase: possible compensation by macrophage-derived factor XIII.
    Bakker EN; Pistea A; Spaan JA; Rolf T; de Vries CJ; van Rooijen N; Candi E; VanBavel E
    Circ Res; 2006 Jul; 99(1):86-92. PubMed ID: 16741156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of transglutaminase activity in articular chondrocytes through thrombin receptor-mediated factor XIII synthesis.
    Rosenthal AK; Mosesson MW; Gohr CM; Masuda I; Heinkel D; Seibenlist KR
    Thromb Haemost; 2004 Mar; 91(3):558-68. PubMed ID: 14983233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of bone development and extracellular matrix protein genes by RUNX2.
    Komori T
    Cell Tissue Res; 2010 Jan; 339(1):189-95. PubMed ID: 19649655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transglutaminase activity arising from Factor XIIIA is required for stabilization and conversion of plasma fibronectin into matrix in osteoblast cultures.
    Cui C; Wang S; Myneni VD; Hitomi K; Kaartinen MT
    Bone; 2014 Feb; 59():127-38. PubMed ID: 24246248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transglutaminase-catalyzed matrix cross-linking in differentiating cartilage: identification of osteonectin as a major glutaminyl substrate.
    Aeschlimann D; Kaupp O; Paulsson M
    J Cell Biol; 1995 May; 129(3):881-92. PubMed ID: 7730416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures.
    Al-Jallad HF; Nakano Y; Chen JL; McMillan E; Lefebvre C; Kaartinen MT
    Matrix Biol; 2006 Apr; 25(3):135-48. PubMed ID: 16469487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit a antigen and transglutaminase activity.
    Muszbek L; Adány R; Kávai M; Boda Z; Lopaciuk S
    Thromb Haemost; 1988 Apr; 59(2):231-5. PubMed ID: 2898817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor XIII: a coagulation factor with multiple plasmatic and cellular functions.
    Muszbek L; Bereczky Z; Bagoly Z; Komáromi I; Katona É
    Physiol Rev; 2011 Jul; 91(3):931-72. PubMed ID: 21742792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transglutaminase factor XIIIA in the cartilage of developing avian long bones.
    Nurminskaya MV; Recheis B; Nimpf J; Magee C; Linsenmayer TF
    Dev Dyn; 2002 Jan; 223(1):24-32. PubMed ID: 11803567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin (5-HT) inhibits Factor XIII-A-mediated plasma fibronectin matrix assembly and crosslinking in osteoblast cultures via direct competition with transamidation.
    Cui C; Kaartinen MT
    Bone; 2015 Mar; 72():43-52. PubMed ID: 25460579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma transglutaminase factor XIII induces microvessel ingrowth into biodegradable hydroxyapatite implants in rats.
    Kilian O; Fuhrmann R; Alt V; Noll T; Coskun S; Dingeldein E; Schnettler R; Franke RP
    Biomaterials; 2005 May; 26(14):1819-27. PubMed ID: 15576156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental expression and hormonal regulation of the rat matrix Gla protein (MGP) gene in chondrogenesis and osteogenesis.
    Barone LM; Owen TA; Tassinari MS; Bortell R; Stein GS; Lian JB
    J Cell Biochem; 1991 Aug; 46(4):351-65. PubMed ID: 1757478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of bone-related proteins, osteocalcin and osteopontin, and their matrix ultrastructural localization with development of chondrocyte hypertrophy in vitro.
    Lian JB; McKee MD; Todd AM; Gerstenfeld LC
    J Cell Biochem; 1993 Jun; 52(2):206-19. PubMed ID: 8366137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistological analysis of transglutaminase factor XIIIA expression in mouse embryonic growth plate.
    Nurminskaya MV; Linsenmayer TF
    J Orthop Res; 2002 May; 20(3):575-8. PubMed ID: 12038633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dentin matrix protein 1, a target molecule for Cbfa1 in bone, is a unique bone marker gene.
    Fen JQ; Zhang J; Dallas SL; Lu Y; Chen S; Tan X; Owen M; Harris SE; MacDougall M
    J Bone Miner Res; 2002 Oct; 17(10):1822-31. PubMed ID: 12369786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Structure and function of blood coagulation factor XIII (transglutaminase)].
    Takahashi N
    Tanpakushitsu Kakusan Koso; 1987 Jul; 32(8):1041-59. PubMed ID: 2890181
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of tissue transglutaminase in skeletal tissues correlates with events of terminal differentiation of chondrocytes.
    Aeschlimann D; Wetterwald A; Fleisch H; Paulsson M
    J Cell Biol; 1993 Mar; 120(6):1461-70. PubMed ID: 8095503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vis-à-vis cells and the priming of bone formation.
    Riminucci M; Bradbeer JN; Corsi A; Gentili C; Descalzi F; Cancedda R; Bianco P
    J Bone Miner Res; 1998 Dec; 13(12):1852-61. PubMed ID: 9844103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.